180 related articles for article (PubMed ID: 9269755)
1. Aberrations of the B-cell receptor B29 (CD79b) gene in chronic lymphocytic leukemia.
Thompson AA; Talley JA; Do HN; Kagan HL; Kunkel L; Berenson J; Cooper MD; Saxon A; Wall R
Blood; 1997 Aug; 90(4):1387-94. PubMed ID: 9269755
[TBL] [Abstract][Full Text] [Related]
2. Aberrant B cell receptor signaling from B29 (Igbeta, CD79b) gene mutations of chronic lymphocytic leukemia B cells.
Gordon MS; Kato RM; Lansigan F; Thompson AA; Wall R; Rawlings DJ
Proc Natl Acad Sci U S A; 2000 May; 97(10):5504-9. PubMed ID: 10792036
[TBL] [Abstract][Full Text] [Related]
3. Widespread B29 (CD79b) gene defects and loss of expression in chronic lymphocytic leukemia.
Thompson AA; Do HN; Saxon A; Wall R
Leuk Lymphoma; 1999 Feb; 32(5-6):561-9. PubMed ID: 10048429
[TBL] [Abstract][Full Text] [Related]
4. Analysis of the B-cell receptor B29 (CD79b) gene in familial chronic lymphocytic leukemia.
Payelle-Brogard B; Magnac C; Mauro FR; Mandelli F; Dighiero G
Blood; 1999 Nov; 94(10):3516-22. PubMed ID: 10552962
[TBL] [Abstract][Full Text] [Related]
5. An alternatively spliced form of CD79b gene may account for altered B-cell receptor expression in B-chronic lymphocytic leukemia.
Alfarano A; Indraccolo S; Circosta P; Minuzzo S; Vallario A; Zamarchi R; Fregonese A; Calderazzo F; Faldella A; Aragno M; Camaschella C; Amadori A; Caligaris-Cappio F
Blood; 1999 Apr; 93(7):2327-35. PubMed ID: 10090943
[TBL] [Abstract][Full Text] [Related]
6. Somatic hypermutation of the B cell receptor genes B29 (Igbeta, CD79b) and mb1 (Igalpha, CD79a).
Gordon MS; Kanegai CM; Doerr JR; Wall R
Proc Natl Acad Sci U S A; 2003 Apr; 100(7):4126-31. PubMed ID: 12651942
[TBL] [Abstract][Full Text] [Related]
7. Differential expression of B29 (CD79b) and mb-1 (CD79a) proteins in acute lymphoblastic leukaemia.
Astsaturov IA; Matutes E; Morilla R; Seon BK; Mason DY; Farahat N; Catovsky D
Leukemia; 1996 May; 10(5):769-73. PubMed ID: 8656670
[TBL] [Abstract][Full Text] [Related]
8. Defective assembly of the B-cell receptor chains accounts for its low expression in B-chronic lymphocytic leukaemia.
Payelle-Brogard B; Magnac C; Alcover A; Roux P; Dighiero G
Br J Haematol; 2002 Sep; 118(4):976-85. PubMed ID: 12199775
[TBL] [Abstract][Full Text] [Related]
9. Heterogeneous intracellular expression of B-cell receptor components in B-cell chronic lymphocytic leukaemia (B-CLL) cells and effects of CD79b gene transfer on surface immunoglobulin levels in a B-CLL-derived cell line.
Minuzzo S; Indraccolo S; Tosello V; Piovan E; Cabrelle A; Trentin L; Semenzato G; Amadori A
Br J Haematol; 2005 Sep; 130(6):878-89. PubMed ID: 16156858
[TBL] [Abstract][Full Text] [Related]
10. Lower levels of surface B-cell-receptor expression in chronic lymphocytic leukemia are associated with glycosylation and folding defects of the mu and CD79a chains.
Vuillier F; Dumas G; Magnac C; Prevost MC; Lalanne AI; Oppezzo P; Melanitou E; Dighiero G; Payelle-Brogard B
Blood; 2005 Apr; 105(7):2933-40. PubMed ID: 15591116
[TBL] [Abstract][Full Text] [Related]
11. Alternative splicing of CD79a (Ig-alpha/mb-1) and CD79b (Ig-beta/B29) RNA transcripts in human B cells.
Hashimoto S; Chiorazzi N; Gregersen PK
Mol Immunol; 1995 Jun; 32(9):651-9. PubMed ID: 7643857
[TBL] [Abstract][Full Text] [Related]
12. The alternative transcript of CD79b is overexpressed in B-CLL and inhibits signaling for apoptosis.
Cragg MS; Chan HT; Fox MD; Tutt A; Smith A; Oscier DG; Hamblin TJ; Glennie MJ
Blood; 2002 Nov; 100(9):3068-76. PubMed ID: 12384401
[TBL] [Abstract][Full Text] [Related]
13. The novel variants of mb-1 and B29 transcripts generated by alternative mRNA splicing.
Koyama M; Nakamura T; Higashihara M; Herren B; Kuwata S; Shibata Y; Okumura K; Kurokawa K
Immunol Lett; 1995 Sep; 47(3):151-6. PubMed ID: 8747711
[TBL] [Abstract][Full Text] [Related]
14. Alternative splicing of CD79a (Ig alpha) and CD79b (Ig beta) transcripts in human B-CLL cells.
Alfarano A; Circosta P; Vallario A; Camaschella C; Indraccolo S; Amadori A; Caligaris-Cappio F
Curr Top Microbiol Immunol; 1999; 246():241-6; discussion 247-8. PubMed ID: 10396062
[No Abstract] [Full Text] [Related]
15. Comparison of the mRNA expression profile of B-cell receptor components in normal CD5-high B-lymphocytes and chronic lymphocytic leukemia: a key role of ZAP70.
Gladkikh AA; Potashnikova DM; Tatarskiy V; Yastrebova M; Khamidullina A; Barteneva N; Vorobjev I
Cancer Med; 2017 Dec; 6(12):2984-2997. PubMed ID: 29125235
[TBL] [Abstract][Full Text] [Related]
16. Somatic diversification and selection of immunoglobulin heavy and light chain variable region genes in IgG+ CD5+ chronic lymphocytic leukemia B cells.
Hashimoto S; Dono M; Wakai M; Allen SL; Lichtman SM; Schulman P; Vinciguerra VP; Ferrarini M; Silver J; Chiorazzi N
J Exp Med; 1995 Apr; 181(4):1507-17. PubMed ID: 7535340
[TBL] [Abstract][Full Text] [Related]
17. Expression of Ig-beta (CD79b) by chronic lymphocytic leukemia B cells that lack immunoglobulin heavy-chain allelic exclusion.
Rassenti LZ; Kipps TJ
Blood; 2000 Apr; 95(8):2725-7. PubMed ID: 10753858
[TBL] [Abstract][Full Text] [Related]
18. Assembly and intracellular transport of the human B cell antigen receptor complex.
Brouns GS; de Vries E; Borst J
Int Immunol; 1995 Mar; 7(3):359-68. PubMed ID: 7794818
[TBL] [Abstract][Full Text] [Related]
19. B29 gene products complex with immunoglobulins on B lymphocytes.
Ishihara K; Wood WJ; Damore M; Hermanson GG; Wall R; Kincade PW
Proc Natl Acad Sci U S A; 1992 Jan; 89(2):633-7. PubMed ID: 1731334
[TBL] [Abstract][Full Text] [Related]
20. CD79b expression in B cell chronic lymphocytic leukemia: its implication for minimal residual disease detection.
Garcia Vela J; Delgado I; Benito L; Monteserin M; Garcia Alonso L; Somolinos N; Andreu M; Oña F
Leukemia; 1999 Oct; 13(10):1501-5. PubMed ID: 10516749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
